Monoclonal Antibodies for COVID-19 at Pioneer Memorial Hospital:
- Early treatment with monoclonal antibodies may prevent progression to more severe disease and hospitalization.
- Monoclonal antibodies are proteins that mimic the immune system’s ability to fight off harmful viruses.
- Monoclonal antibodies attack the virus and reduce its ability to spread through your body.
- Patient data from clinical trials showed that high risk Covid-19 patients treated with monoclonal antibodies had a 70% reduction in relative risk of progression to severe disease or hospitalization compared to patients who did not receive monoclonal antibodies.
- Outpatient one-time dose.
- Treatments are generally available at little or no cost to eligible patients.
Patients may be eligible for treatment who:
- Have mild to moderate symptoms of Covid-19, and
- Have tested positive for Covid-19, and
- Have had symptoms for 10 days or less (the treatment is most effective when given shortly after symptoms appear, so it is important to get tested and treated as soon as possible), and
- Are at high risk of getting more serious symptoms
Contact your MCHD provider for more information regarding Monoclonal Antibody Therapy for COVID-19.